The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation - PubMed (original) (raw)
. 2009 Jun;10(6):595-602.
doi: 10.1038/ni.1731. Epub 2009 May 3.
Affiliations
- PMID: 19412181
- PMCID: PMC2712126
- DOI: 10.1038/ni.1731
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation
Meghan A Koch et al. Nat Immunol. 2009 Jun.
Abstract
Several subsets of Foxp3(+) regulatory T cells (T(reg) cells) work in concert to maintain immune homeostasis. However, the molecular bases underlying the phenotypic and functional diversity of T(reg) cells remain obscure. We show that in response to interferon-gamma, Foxp3(+) T(reg) cells upregulated the T helper type 1 (T(H)1)-specifying transcription factor T-bet. T-bet promoted expression of the chemokine receptor CXCR3 on T(reg) cells, and T-bet(+) T(reg) cells accumulated at sites of T(H)1 cell-mediated inflammation. Furthermore, T-bet expression was required for the homeostasis and function of T(reg) cells during type 1 inflammation. Thus, in a subset of CD4(+) T cells, the activities of the transcription factors Foxp3 and T-bet are overlaid, which results in T(reg) cells with unique homeostatic and migratory properties optimized for the suppression of T(H)1 responses in vivo.
Figures
Figure 1. CXCR3 expression on Treg cells is T-bet-dependent
(a,b) Representative flow cytometric analysis of CXCR3 and Foxp3 expression by splenocytes isolated from wild-type (WT) mice, (a) or age-matched WT and _Tbx21_–/- mice (b). Plots are gated on CD4+ splenocytes. rIgG2a, isotype control. Numbers display the frequency of cells expressing the indicated markers. Data are representative of greater than six mice analyzed in this fashion. (c) Migration of CD4+Foxp3+ splenocytes isolated from the indicated mice in response to media alone, 100nM CXCL10 or 100nM CCL21 in a transwell chemotaxis assay. Data are mean and s.d. of triplicate measurements. (d) CD45.2 and CXCR3 expression on CD4+Foxp3+ cells recovered from the indicated tissues of recipients of a mixture of CD45.1+ WT and CD45.2+ _Tbx21_–/– BM. Numbers depict the percent of cells positive for the indicated markers. Data are representative of three independent experiments with four mice analyzed per experiment. (e) T-bet expression (open histograms) in CD4+Foxp3+CXCR3+ or CD4+Foxp3+CXCR3- splenocytes. Histograms (right) correspond to indicated gates (left). Data are representative of greater than ten mice analyzed in this fashion.
Figure 2. T-bet+ Treg cells upregulate T-bet in vivo following anti-CD40 treatment
(a) Analysis of T-bet and Foxp3 expression in splenocytes from mice treated with anti-CD40 (top) or rat IgG (bottom). Plots are gated on CD4+ cells. Numbers in plots represent the percentage of cells positive for the indicated markers. Data are representative of three independent experiments. (b) (Top) Splenocytes from TCRβδ-KO recipients of the indicated cells and subjected to the indicated treatment were analyzed by flow cytometry. Dot plots are gated on lymphocytes. Histograms display CXCR3 and T-bet expression in CD4+Foxp3+ cells isolated from anti-CD40- (open histograms) or rat IgG- (shaded histograms) treated mice as indicated. Numbers in dot plots indicate the percentage of Foxp3+CD4+ cells of total lymphocytes. Data are representative of two independent experiments with three mice per group.
Figure 3. IFN-γR and STAT1 are promote expression of T-bet and CXCR3 by Treg cells
(a) CXCR3 expression on splenocytes from WT, _Ifngr1_–/–, or _Stat1_–/– mice as indicated (n≥ three per genotype). Histograms are gated on CD4+Foxp3+ cells. Numbers indicate the percent of CXCR3+ cells among total CD4+Foxp3+. (b) Graph depicts the ratio of WT:_Ifngr1_–/–-derived lymphocytes among CXCR3+CD4+Foxp3+, CXCR3-CD4+Foxp3+ or CD4-B220+ peripheral blood lymphocytes of 11 mixed BM chimeras. Each point represents an individual mouse. Statistical significance was determined using a two-way repeated measures ANOVA. A Bonferroni post-test was used to obtain the _P_-value for the indicated pairwise comparison. (c) CXCR3 and T-bet expression on splenocytes isolated from a WT:_Ifngr1_–/– BM chimera. Plots are gated on CD4+Foxp3+ cells from WT-derived (CD45.1+) or _Ifngr1_–/– -derived (CD45.2+) BM as indicated. Numbers in dot plots indicate the percent of cells positive for CXCR3. Data are representative of four mice analyzed in this fashion.
Figure 4. Functional characterization of T-bet+ Foxp3+ Treg cells
(a) IFN-γ and Foxp3 expression by T-bet+CD4+ (top right) and T-bet-CD4+ (bottom right) lymphocytes isolated from WT mice following stimulation with PMA and ionomycin. Left histogram is gated on total CD4+ cells, and indicates gates used to define the populations depicted in the dot plots. Numbers in plot indicate the percent of cells positive for the indicated markers. Data are representative of greater than five mice analyzed in this fashion. (b) Proliferation of CFSE-labeled CD4+CD25- T cells incubated with irradiated splenocytes, anti-CD3 and anti-CD28, with or without varying concentrations of CXCR3+ Treg cells. Numbers above histograms indicate Treg:Teff cell ratio in each culture. No stimulation, control without irradiated splenocytes and stimulatory antibodies. Numbers indicate the percent of Teff cells that are CFSE-. (c) Expression of the indicated markers on gated CD4+CXCR3+ (top) or CD4+CXCR3- (bottom) splenocytes from WT mice. Numbers represent the frequency of cells positive for each marker as a fraction of total CD4+Foxp3+ cells. Data are representative of three mice analyzed in this fashion.
Figure 5. Decreased proliferation of T-bet-deficient Treg cells following anti-CD40 treatment
(a) Experimental design showing cell transfer and treatment schedule. Briefly, a mixture of CD45.1+ WT and CD45.2+ _Tbx21_–/– Treg cells were injected into TCRβδ-KO mice, followed by treatment with the indicated antibodies. BrdU was added to the drinking water when indicated. (b) CD45.1 expression on splenocytes of recipient mice was analyzed by flow cytometry. Histograms are gated on Foxp3+CD4+TCRβ+B220- cells, and numbers indicate the percent of cells positive and negative for CD45.1. Graphs show absolute numbers of WT- and _Tbx21_–/–-derived Treg cells recovered from the spleens of recipient mice. Each point represents an individual treated mouse. (c) BrdU incorporation by splenocytes of recipient mice was analyzed by flow cytometry. Dot plots are gated on Foxp3+CD4+TCRβ+B220- splenocytes. Numbers in plots indicate percentage of BrdU+ cells among total WT- (CD45.1+) or _Tbx21_–/–-derived (CD45.1-) Treg cells. Graphs depict the frequency of BrdU+ cells among WT and _Tbx21_–/–-derived Treg cell populations. For b and c, statistical significance was determined using a two-way repeated measures ANOVA. Bonferroni post-tests were used to obtain the _P_-values for the indicated pairwise comparisons. Data are representative of three independent experiments with three or greater mice per group
Figure 6. Impaired homeostasis of T-bet-deficient Treg cells during persistent Mtb infection
(a) T-bet and Foxp3 expression on cells isolated from the indicated tissues of an _Mtb_-infected mouse (left) or an uninfected age-matched control (right). Plots are gated on CD4+ T cells. Numbers display the percent of cells in each of the indicated quadrants. Data are representative of five independent experiments. (b) (Left) Recipients of a mixture of WT (CD45.1+) and _Tbx21_–/– (CD45.2+) BM were infected with Mtb for 105 days. Cells isolated from the indicated organs were analyzed by flow cytometry. Contour plots depict gating strategy, with numbers indicating the percent of cells positive for the indicated markers. Graphs depict the ratio of WT and _Tbx21_–/–-derived cells among gated CD4-CD8- DN, CD4+Foxp3+ Treg and CD4+Foxp3-CD44hi Teff populations. Each point represents a value from an individual infected BM chimera. Data are representative of two independent experiments (n=3 per experiment).
Figure 7. T-bet expression in Treg cells is critical for control of TH1-mediated inflammatory responses
(a) CD44 and T-bet expression (top) or IFN-γ production (bottom) by splenocytes isolated from age-matched WT or scurfy (sf) mice, as measured by flow cytometry. Plots are gated on CD4+Foxp3- cells. Numbers in plots indicate the percent of T-bet+ (top) or IFN-γ+ (bottom) cells among total CD44hi CD4+Foxp3-cells. Data are representative of three independent experiments. (b) T-bet and Foxp3 expression by splenocytes isolated from age-matched WT mice or sf mice given WT Treg cells. Plots are gated on CD4+CD8- lymphocytes. Numbers in plots indicate the percentage of CD4+Foxp3+ cells expressing T-bet. Data are representative of six independent experiments. (c) Cells isolated from the spleen and peripheral lymph nodes (pLN) of sf neonate recipients of WT or _Tbx21_-/- Treg cells were analyzed by flow cytometry. Numbers in plots indicate fraction of Foxp3+ T cells among total CD4+ reg splenocytes. (d, e) Flow cytometric and quantitative analysis of splenocytes isolated from sf mice given WT or _Tbx21_–/– Treg cells, or from age-matched WT mice. Splenocytes in e were stimulated with PMA and ionomycin prior to analysis. Plots are gated on CD4+Foxp3- cells. Numbers in plots display percentage of T-bet+ (d) and IFN-γ+ (e) cells among total CD4+Foxp3-CD44hi cells. (f) Photograph of representative spleen and peripheral LNs isolated from 6 week old sf mice given WT (left) or _Tbx21_–/– (right) Treg cells as neonates. Representative of six independent experiments. For c, d and e, each point represents an individual mouse, and significance was measured using two-tailed, unpaired student’s t tests.
Comment in
- Hybrid Treg cells: steel frames and plastic exteriors.
Barnes MJ, Powrie F. Barnes MJ, et al. Nat Immunol. 2009 Jun;10(6):563-4. doi: 10.1038/ni0609-563. Nat Immunol. 2009. PMID: 19448654 No abstract available.
Similar articles
- T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor β2.
Koch MA, Thomas KR, Perdue NR, Smigiel KS, Srivastava S, Campbell DJ. Koch MA, et al. Immunity. 2012 Sep 21;37(3):501-10. doi: 10.1016/j.immuni.2012.05.031. Epub 2012 Sep 6. Immunity. 2012. PMID: 22960221 Free PMC article. - Plasmodium chabaudi AS Infection Induces CD4+ Th1 Cells and Foxp3+T-bet+ Regulatory T Cells That Express CXCR3 and Migrate to CXCR3 Ligands.
Berretta F, Piccirillo CA, Stevenson MM. Berretta F, et al. Front Immunol. 2019 Mar 11;10:425. doi: 10.3389/fimmu.2019.00425. eCollection 2019. Front Immunol. 2019. PMID: 30915078 Free PMC article. - T-bet regulates differentiation of forkhead box protein 3+ regulatory T cells in programmed cell death-1-deficient mice.
Tahara M, Kondo Y, Yokosawa M, Tsuboi H, Takahashi S, Shibayama S, Matsumoto I, Sumida T. Tahara M, et al. Clin Exp Immunol. 2015 Feb;179(2):197-209. doi: 10.1111/cei.12455. Clin Exp Immunol. 2015. PMID: 25219397 Free PMC article. - Transcription Factor T-bet Orchestrates Lineage Development and Function in the Immune System.
Kallies A, Good-Jacobson KL. Kallies A, et al. Trends Immunol. 2017 Apr;38(4):287-297. doi: 10.1016/j.it.2017.02.003. Epub 2017 Mar 7. Trends Immunol. 2017. PMID: 28279590 Review. - Phenotypical and functional specialization of FOXP3+ regulatory T cells.
Campbell DJ, Koch MA. Campbell DJ, et al. Nat Rev Immunol. 2011 Feb;11(2):119-30. doi: 10.1038/nri2916. Nat Rev Immunol. 2011. PMID: 21267013 Free PMC article. Review.
Cited by
- CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner.
Lo JW, Schroeder JH, Roberts LB, Mohamed R, Cozzetto D, Beattie G, Omer OS, Ross EM, Heuts F, Jowett GM, Read E, Madgwick M, Neves JF, Korcsmaros T, Jenner RG, Walker LSK, Powell N, Lord GM. Lo JW, et al. Nat Commun. 2024 Nov 4;15(1):9520. doi: 10.1038/s41467-024-51719-6. Nat Commun. 2024. PMID: 39496592 Free PMC article. - CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation.
Huang M, Ke Z, Lyu MA, Masarova L, Sadeghi T, Flowers CR, Parmar S. Huang M, et al. iScience. 2024 Aug 27;27(9):110830. doi: 10.1016/j.isci.2024.110830. eCollection 2024 Sep 20. iScience. 2024. PMID: 39314243 Free PMC article. - Dietary fibers boost gut microbiota-produced B vitamin pool and alter host immune landscape.
Grant ET, Parrish A, Boudaud M, Hunewald O, Hirayama A, Ollert M, Fukuda S, Desai MS. Grant ET, et al. Microbiome. 2024 Sep 23;12(1):179. doi: 10.1186/s40168-024-01898-7. Microbiome. 2024. PMID: 39307855 Free PMC article. - Phenotypic profiling of human induced regulatory T cells at early differentiation: insights into distinct immunosuppressive potential.
Kattelus R, Starskaia I, Lindén M, Batkulwar K, Pietilä S, Moulder R, Marson A, Rasool O, Suomi T, Elo LL, Lahesmaa R, Buchacher T. Kattelus R, et al. Cell Mol Life Sci. 2024 Sep 12;81(1):399. doi: 10.1007/s00018-024-05429-3. Cell Mol Life Sci. 2024. PMID: 39264416 Free PMC article. - Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype.
Ansari AW, Jayakumar MN, Ahmad F, Venkatachalam T, Salameh L, Unnikannan H, Raheed T, Mohammed AK, Mahboub B, Al-Ramadi BK, Hamid Q, Steinhoff M, Hamoudi R. Ansari AW, et al. Front Immunol. 2024 Aug 15;15:1447625. doi: 10.3389/fimmu.2024.1447625. eCollection 2024. Front Immunol. 2024. PMID: 39211048 Free PMC article.
References
- Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 2009 - PubMed
- Reiner SL. Development in motion: helper T cells at work. Cell. 2007;129:33–36. - PubMed
- Szabo SJ, et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100:655–669. - PubMed
- Beima KM, et al. T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J. Biol. Chem. 2006;281:11992–12000. - PubMed
- Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775–787. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R21 AI069889-02/AI/NIAID NIH HHS/United States
- R01 DK072295/DK/NIDDK NIH HHS/United States
- R01 AI067750-03/AI/NIAID NIH HHS/United States
- R01 DK072295-04/DK/NIDDK NIH HHS/United States
- DK072295/DK/NIDDK NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R21 AI069889/AI/NIAID NIH HHS/United States
- AI067750/AI/NIAID NIH HHS/United States
- T32 CA009537/CA/NCI NIH HHS/United States
- T32-CA009537/CA/NCI NIH HHS/United States
- R56 AI067750/AI/NIAID NIH HHS/United States
- R01 AI067750/AI/NIAID NIH HHS/United States
- AI069889/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials